APA (7th ed.) Citation

Miura-Takahashi, E., Tsudome, R., Suematsu, Y., Tachibana, T., Kato, Y., Kuwano, T., . . . Miura, S. (2025). An elevated level of soluble suppression of tumorigenicity 2, but not galectin-3, is associated with the presence of coronary artery disease in hypertensive patients. Hypertension research, 48(2), 650-661. https://doi.org/10.1038/s41440-024-01934-x

Chicago Style (17th ed.) Citation

Miura-Takahashi, Erika, et al. "An Elevated Level of Soluble Suppression of Tumorigenicity 2, but Not Galectin-3, Is Associated with the Presence of Coronary Artery Disease in Hypertensive Patients." Hypertension Research 48, no. 2 (2025): 650-661. https://doi.org/10.1038/s41440-024-01934-x.

MLA (9th ed.) Citation

Miura-Takahashi, Erika, et al. "An Elevated Level of Soluble Suppression of Tumorigenicity 2, but Not Galectin-3, Is Associated with the Presence of Coronary Artery Disease in Hypertensive Patients." Hypertension Research, vol. 48, no. 2, 2025, pp. 650-661, https://doi.org/10.1038/s41440-024-01934-x.